Patent details

EP3055333 Title: USE OF A PCSK9 INHIBITOR TO TREAT HYPERLIPIDEMIA

Basic Information

Publication number:
EP3055333
PCT Application Number:
US2014060109
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP148025273
PCT Publication Number:
WO2015054619
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
USE OF A PCSK9 INHIBITOR TO TREAT HYPERLIPIDEMIA
French Title of Invention:
UTILISATION D'INHIBITEUR DE PCSK9 POUR TRAITER L'HYPERLIPIDÉMIE
German Title of Invention:
VERWENDUNG VON PCSK9-INHIBITOREN ZUR BEHANDLUNG VON HYPERLIPIDÄMIE
SPC Number:

Dates

Filing date:
10/10/2014
Grant date:
04/12/2019
EP Publication Date:
17/08/2016
PCT Publication Date:
16/04/2015
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
04/12/2019
EP B1 Publication Date:
04/12/2019
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
10/10/2020
Expiration date:
10/10/2034
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
27/11/2019
 
 

Name:
Regeneron Pharmaceuticals, Inc.
Address:
777 Old Saw Mill River Road, Tarrytown, NY 10591, United States (US)

Name:
Sanofi Biotechnology
Address:
54 rue La Boétie, 75008 Paris, France (FR)

Inventor

1

Name:
PORDY, Robert, C.
Address:
United States (US)

2

Name:
HANOTIN, Corinne
Address:
France (FR)

3

Name:
CHAUDHARI, Umesh
Address:
United States (US)

4

Name:
BESSAC, Laurence
Address:
France (FR)

5

Name:
SASIELA, William, J.
Address:
United States (US)

6

Name:
SCHWEMMER GIPE, Daniel A.,
Address:
United States (US)

7

Name:
BACCARA-DINET, Marie
Address:
France (FR)

Priority

1

Priority Number:
201361890154 P
Priority Date:
11/10/2013
Priority Country:
United States (US)

2

Priority Number:
201461923103 P
Priority Date:
02/01/2014
Priority Country:
United States (US)

3

Priority Number:
201461955514 P
Priority Date:
19/03/2014
Priority Country:
United States (US)

4

Priority Number:
201462004620 P
Priority Date:
29/05/2014
Priority Country:
United States (US)

5

Priority Number:
201462025104 P
Priority Date:
16/07/2014
Priority Country:
United States (US)

6

Priority Number:
14306221
Priority Date:
31/07/2014
Priority Country:
European Patent Office (EPO) (EP)

7

Priority Number:
201462054571 P
Priority Date:
24/09/2014
Priority Country:
United States (US)

8

Priority Number:
14306584
Priority Date:
09/10/2014
Priority Country:
European Patent Office (EPO) (EP)

Classification

IPC classification:
A61K 39/395; A61P 3/06; C07K 16/40;

Publication

European Patent Bulletin

1

Issue number:
201949
Publication date:
04/12/2019
Description:
Grant (B1)

2

Issue number:
202001
Publication date:
01/01/2020
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages